ATE399860T1 - Mutation innerhalb des connexin 26 gens und bezug zu prelingualer syndromloser taubheit sowie detektionsverfahren - Google Patents

Mutation innerhalb des connexin 26 gens und bezug zu prelingualer syndromloser taubheit sowie detektionsverfahren

Info

Publication number
ATE399860T1
ATE399860T1 AT98945246T AT98945246T ATE399860T1 AT E399860 T1 ATE399860 T1 AT E399860T1 AT 98945246 T AT98945246 T AT 98945246T AT 98945246 T AT98945246 T AT 98945246T AT E399860 T1 ATE399860 T1 AT E399860T1
Authority
AT
Austria
Prior art keywords
prelingual
mutation
syndromeless
connexin
deafness
Prior art date
Application number
AT98945246T
Other languages
German (de)
English (en)
Inventor
Christine Petit
Francoise Denoyelle-Gryson
Dominique Weil
Sandrine Marlin-Duvernois
Jean-Luc Guesdon
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE399860T1 publication Critical patent/ATE399860T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT98945246T 1997-08-15 1998-08-14 Mutation innerhalb des connexin 26 gens und bezug zu prelingualer syndromloser taubheit sowie detektionsverfahren ATE399860T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5586397P 1997-08-15 1997-08-15

Publications (1)

Publication Number Publication Date
ATE399860T1 true ATE399860T1 (de) 2008-07-15

Family

ID=22000653

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98945246T ATE399860T1 (de) 1997-08-15 1998-08-14 Mutation innerhalb des connexin 26 gens und bezug zu prelingualer syndromloser taubheit sowie detektionsverfahren

Country Status (11)

Country Link
US (7) US5998147A (enExample)
EP (1) EP1003865B1 (enExample)
JP (1) JP4418587B2 (enExample)
AT (1) ATE399860T1 (enExample)
CA (3) CA2852463C (enExample)
CY (1) CY1108771T1 (enExample)
DE (1) DE69839671D1 (enExample)
DK (1) DK1003865T3 (enExample)
ES (1) ES2308813T3 (enExample)
PT (1) PT1003865E (enExample)
WO (1) WO1999009210A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE399860T1 (de) * 1997-08-15 2008-07-15 Pasteur Institut Mutation innerhalb des connexin 26 gens und bezug zu prelingualer syndromloser taubheit sowie detektionsverfahren
US6013449A (en) * 1997-11-26 2000-01-11 The United States Of America As Represented By The Department Of Health And Human Services Probe-based analysis of heterozygous mutations using two-color labelling
WO2002061410A1 (en) * 2000-09-01 2002-08-08 Spectrumedix Corporation System and method for temperature gradient capillary electrophoresis
WO2002031199A1 (en) * 2000-10-11 2002-04-18 Spectrumedix Corporation System and method for determining the presence of methylated cytosines in polynucleotides
JP2005504534A (ja) 2001-09-19 2005-02-17 アメリカ合衆国政府 トランスダクチン−１及びトランスダクチン−２並びに遺伝性聴覚障害への適用
WO2003033743A1 (en) * 2001-10-18 2003-04-24 Spectrumedix Corporation System and method for temperature gradient capillary electrophoresis
NL1019226C2 (nl) * 2001-10-25 2003-04-28 Multigen Holding S A Werkwijze voor het detecteren van een mutatie die verband houdt met plaveiselcelcarcinoom.
EP1308458A1 (en) * 2001-10-30 2003-05-07 GenOdyssee New polynucleotides and polypeptides of the CX26 gene
US6872530B2 (en) * 2002-04-24 2005-03-29 Spectrumedix, Llc Method for determining the presence of DNA variants using peptide nucleic acid probes
AU2003253922A1 (en) * 2002-07-15 2004-02-02 Spectrumedix Llc System and method for determining known dna variants with temperature gradient electrophoresis
WO2004007690A2 (en) * 2002-07-16 2004-01-22 Spectrumedix Llc Method and system for comparative genomics for organisms using temperature gradient electrophoresis
AU2002952702A0 (en) * 2002-11-18 2002-11-28 Murdoch Childrens Research Institute A diagnostic assay
US7700750B2 (en) * 2003-01-09 2010-04-20 Third Wave Technologies, Inc. Connexin allele detection assays
US20040166495A1 (en) * 2003-02-24 2004-08-26 Greinwald John H. Microarray-based diagnosis of pediatric hearing impairment-construction of a deafness gene chip
US7303879B2 (en) * 2003-07-31 2007-12-04 Applera Corporation Determination of SNP allelic frequencies using temperature gradient electrophoresis
US7166433B2 (en) 2004-03-03 2007-01-23 The United States Of America As Represented By The Department Of Health And Human Services Transductin-1 and transductin-2 and applications to hereditary deafness
US7276804B2 (en) * 2005-06-22 2007-10-02 C.E. Niehoff & Co. Voltage regulator with improved protection and warning system
US20070134691A1 (en) * 2005-11-21 2007-06-14 Iris Schrijver Methods and compositions for determining whether a subject carries a gene mutation associated with hereditary hearing loss
CA3141309A1 (en) * 2019-05-22 2020-11-26 Regeneron Pharmaceuticals, Inc. Synaptojanin 2 (synj2) variants and uses thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228805A (en) 1978-11-08 1980-10-21 Rca Corporation Method of measuring blood perfusion
US4709703A (en) 1985-11-12 1987-12-01 Mayo Foundation Imaging system and method using radiopaque microspheres for evaluation of organ tissue perfusion
US5480382A (en) 1989-01-09 1996-01-02 Pilot Cardiovascular Systems, Inc. Steerable medical device
US5552541A (en) * 1990-06-20 1996-09-03 Beckman Instruments, Inc. Haptenic probes for detecting capture polynucleotides
US5190050A (en) 1991-11-08 1993-03-02 Electro-Catheter Corporation Tip deflectable steerable catheter
US5312415A (en) 1992-09-22 1994-05-17 Target Therapeutics, Inc. Assembly for placement of embolic coils using frictional placement
US6165139A (en) 1993-03-01 2000-12-26 Fonar Corporation Remotely steerable guide wire with external control wires
US5769796A (en) 1993-05-11 1998-06-23 Target Therapeutics, Inc. Super-elastic composite guidewire
US5358479A (en) 1993-12-06 1994-10-25 Electro-Catheter Corporation Multiform twistable tip deflectable catheter
US5661122A (en) 1994-04-15 1997-08-26 Genentech, Inc. Treatment of congestive heart failure
US5814062A (en) 1994-12-22 1998-09-29 Target Therapeutics, Inc. Implant delivery assembly with expandable coupling/decoupling mechanism
EP0725136A1 (en) * 1995-02-03 1996-08-07 Institut Pasteur Nucleotide and peptide sequences of the USHER-lB gene diagnostic and therapeutic applications
US5855577A (en) 1996-09-17 1999-01-05 Eclipse Surgical Technologies, Inc. Bow shaped catheter
US6106473A (en) 1996-11-06 2000-08-22 Sts Biopolymers, Inc. Echogenic coatings
US5967991A (en) 1996-12-03 1999-10-19 Echocath, Inc. Drive apparatus for an interventional medical device used in an ultrasonic imaging system
US5876373A (en) 1997-04-04 1999-03-02 Eclipse Surgical Technologies, Inc. Steerable catheter
ATE399860T1 (de) 1997-08-15 2008-07-15 Pasteur Institut Mutation innerhalb des connexin 26 gens und bezug zu prelingualer syndromloser taubheit sowie detektionsverfahren
US5984929A (en) 1997-08-29 1999-11-16 Target Therapeutics, Inc. Fast detaching electronically isolated implant
US6179809B1 (en) 1997-09-24 2001-01-30 Eclipse Surgical Technologies, Inc. Drug delivery catheter with tip alignment
JP4065663B2 (ja) 1997-10-02 2008-03-26 ボストン サイエンティフィック リミテッド 繊維を体内へと送達するためのデバイス
US6053870A (en) 1997-11-08 2000-04-25 Angiodynamics, Inc. Ultrasonic visible surgical needle
US6248112B1 (en) 1998-09-30 2001-06-19 C. R. Bard, Inc. Implant delivery system
US6146339A (en) 1999-05-24 2000-11-14 Advanced Cardiovascular Systems Guide wire with operator controllable tip stiffness
US6277082B1 (en) 1999-07-22 2001-08-21 C. R. Bard, Inc. Ischemia detection system

Also Published As

Publication number Publication date
US20120322059A1 (en) 2012-12-20
CA2301301C (en) 2010-12-07
US9868989B2 (en) 2018-01-16
JP4418587B2 (ja) 2010-02-17
US9169517B2 (en) 2015-10-27
EP1003865B1 (en) 2008-07-02
US8143000B2 (en) 2012-03-27
US20160076101A1 (en) 2016-03-17
US6485908B1 (en) 2002-11-26
WO1999009210A2 (en) 1999-02-25
CA2720384C (en) 2014-08-12
US20090104600A1 (en) 2009-04-23
PT1003865E (pt) 2008-10-14
US20030170676A1 (en) 2003-09-11
CA2301301A1 (en) 1999-02-25
US7258975B2 (en) 2007-08-21
CY1108771T1 (el) 2014-04-09
WO1999009210A3 (en) 1999-04-15
DE69839671D1 (de) 2008-08-14
DK1003865T3 (da) 2008-11-10
JP2001514904A (ja) 2001-09-18
CA2720384A1 (en) 1999-02-25
US5998147A (en) 1999-12-07
CA2852463C (en) 2017-08-29
US8455195B2 (en) 2013-06-04
CA2852463A1 (en) 1999-02-25
EP1003865A2 (en) 2000-05-31
ES2308813T3 (es) 2008-12-01
US20140113285A1 (en) 2014-04-24

Similar Documents

Publication Publication Date Title
CY1108771T1 (el) Μεταλλαξη εντος του γονιδιου κοννεξινης 26 υπευθυνου για προγλωσσικη μη-συνδρομικη κωφωση και μεθοδος ανιχνευσης
ATE247718T1 (de) Erkennung einer genetischen prädisposition fur osteoporose
DE69013516D1 (de) Calciumhypochloridzusammensetzungen zum verhindern von kesselsteinbildung und methode zu deren verwendung.
HUP9900623A2 (hu) Növényi protoporfirinogén oxidáz génekből származó promoterek
ATE412002T1 (de) Gruppen zum einfangen von nukleinsäuren
ATE329940T1 (de) Katalysatorzusammensetzung und verfahren für olefinpolymerisation
DE69621507D1 (de) Verfahren zur molekularen Indexierung von Genen unter Verwendung von Restriktionsenzymen
DE58908694D1 (de) Oligonucleotidbank und verfahren zur dna-sequenzierung.
FI951612A0 (fi) Menetelmiä synteettisten oligonukleotidien sekvensoimiseksi, jotka sisältävät nukleotidien välisiä ei-fosfodiesterisidoksia
DE69425379D1 (de) Elongation, amplifikation und sequenzierung unter verwendung eines chimären oligonucleotids
DE69107733D1 (de) Titanium-enthaltende Mittel zur Verhinderung von Ablagerungen bei thermischen Crackprozessen.
ATE271037T1 (de) Substituierte karbazole, verfahren zu ihrer herstellung und ihre verwendung als spla2- inhibitoren
DE69426033D1 (de) Für die alpha-1e untereinheit des menschlichen kalziumkanals kodierende dna
Fenster et al. Chloroplast DNA and isozyme diversity in two Mimulus species (Scrophulariaceae) with contrasting mating systems
DE69330463D1 (de) Isolierte nukleotid-sequenzen zum nachweis von neisseria gonorrhoeae
DE59001452D1 (de) Verfahren zur optimierung der verbrennung von kraftstoffen bei minimaler co-emission und vorrichtung zur durchfuehrung des verfahrens.
DE69610537D1 (de) Verfahren zum Nachweis von Mikroorganismen
DE69615285D1 (de) System zum Raffinieren von Gasen
DE69635446D1 (de) Pflanzenpromoter und dessen verwendung zur genexpression
DZ2292A1 (fr) Méthode concernant l'immortalité des cellules.
Frassati et al. Distribution of killer‐cell immunoglobulin‐like receptor (KIR) in Comoros and Southeast France
ATE217229T1 (de) Diamantierter sägedraht zum scheiden von steinartigen materialien und verfahren zu seiner herstellung
DE3770739D1 (de) Morpholin-, piperidin- und tetrahydropyridinderivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
DE59813664D1 (de) Verfahren zum screening von antimykotisch wirkenden substanzen
DE58908066D1 (de) Bitumengranulat und Verfahren zu seiner Herstellung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1003865

Country of ref document: EP